Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arcturus Therapeutics Ltd (NASDAQ:ARCT)

9.10
Delayed Data
As of Nov 22
 +0.2299 / +2.59%
Today’s Change
5.81
Today|||52-Week Range
18.04
-38.10%
Year-to-Date
SECTOR
--
INDUSTRY
--
MARKET CAP
$35.8M

Company Description

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of RNA medicines using proprietary lipid-mediated delivery system (LUNAR) and UNA Oligomer chemistry technologies. The company was founded in March 2013 and is headquartered in San Diego, CA.

Contact Information

Arcturus Therapeutics Ltd.
10628 Science Center Drive
San Diego California 92121
P:(858) 900-2660
Investor Relations:

Employees

Shareholders

Other institutional8.40%
Mutual fund holders19.00%
Individual stakeholders--

Top Executives

Joseph E. PaynePresident, Chief Executive Officer & Director
Padmanabh ChivukulaCOO, Director & Chief Scientific Officer